Jagsonpal Pharmaceuticals shareholders and shareholding pattern
NSE: JAGSNPHARMBSE: 507789Pharmaceuticals & BiotechnologySmall Cap
Last close ₹211.76up ₹0.90 (0.43%)BSE ₹211.70
Share price at the NSE close on 23 Oct 2026. Previous close ₹210.86.
52-week range of traded prices to 23 Oct 2026
₹155.00Low, 22 Jan 2026₹264.50High, 30 Jun 2026
- Next results date: the board meets on 28 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,399 Cr1,360th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 29 Jul 2026
- 30.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 Apr 2026
- 5.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.89%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 29 Jul 2026
- 17.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 29 Jul 2026
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 Apr 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 70,16245.8% delivered
Who owns Jagsonpal Pharmaceuticals, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters68.81%
- Foreign institutions2.14%
- Indian institutions1.65%
- Individuals and others27.40%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 13 Jan | Mar 2017Filed 25 Apr | Jun 2017Filed 12 Jul | Sep 2017Filed 11 Oct | Dec 2017Filed 11 Jan | Mar 2018Filed 11 May | Jun 2018Filed 12 Jul | Sep 2018Filed 16 Oct | Dec 2018Filed 23 Jan | Mar 2019Filed 20 Apr | Jun 2019Filed 18 Jul | Sep 2019Filed 19 Oct | Dec 2019Filed 17 Jan | Mar 2020Filed 13 May | Jun 2020Filed 21 Jul | Sep 2020Filed 20 Oct | Dec 2020Filed 20 Jan | Mar 2021Filed 19 Apr | Jun 2021Filed 19 Jul | Sep 2021Filed 21 Oct | Dec 2021Filed 19 Jan | Mar 2022Filed 20 Apr | Jun 2022Filed 21 Jul | Sep 2022Filed 20 Oct | Dec 2022Filed 20 Jan | Mar 2023Filed 19 Apr | Jun 2023Filed 14 Jul | Sep 2023Filed 11 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 19 Apr | Jun 2024Filed 18 Jul | Sep 2024Filed 20 Oct | Dec 2024Filed 3 Jan | Mar 2025Filed 18 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 17 Oct | Dec 2025Filed 15 Jan | Mar 2026Filed 21 Apr | Jun 2026Filed 13 Jul | Sep 2026Filed 19 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69.17% | 69.17% | 69.17% | 69.17% | 69.17% | 69.17% | 69.17% | 69.51% | 70.12% | 70.26% | 70.33% | 70.34% | 70.34% | 70.34% | 70.34% | 70.34% | 70.34% | 70.34% | 70.34% | 70.34% | 70.34% | 68.71% | 68.71% | 68.71% | 68.71% | 68.71% | 68.71% | 68.71% | 68.48% | 68.09% | 68.04% | 67.97% | 67.81% | 67.78% | 67.65% | 67.54% | 67.39% | 67.89% | 69.05% | 68.81% | |
| Indian promoters | 69.17% | 69.17% | 69.17% | 69.17% | 69.17% | 69.17% | 69.17% | 69.51% | 70.12% | 70.26% | 70.33% | 70.34% | 70.34% | 70.34% | 70.34% | 70.34% | 70.34% | 70.34% | 70.34% | 70.34% | 70.34% | 68.71% | 68.71% | 68.71% | 68.71% | 24.99% | 24.99% | 24.99% | 24.90% | 24.76% | 24.74% | 24.72% | 24.66% | 24.65% | 24.60% | 24.56% | 24.51% | 25.12% | 25.55% | 25.46% |
| Foreign promoters | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 43.73% | 43.73% | 43.73% | 43.58% | 43.33% | 43.30% | 43.25% | 43.15% | 43.13% | 43.05% | 42.98% | 42.88% | 42.77% | 43.50% | 43.35% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 30.83% | 30.83% | 30.83% | 30.83% | 30.83% | 30.83% | 30.83% | 30.49% | 29.88% | 29.74% | 29.67% | 29.66% | 29.66% | 29.66% | 29.66% | 29.66% | 29.66% | 29.66% | 29.66% | 29.66% | 29.66% | 31.29% | 31.29% | 31.29% | 31.29% | 31.29% | 31.29% | 31.29% | 31.52% | 31.91% | 31.96% | 32.03% | 32.19% | 32.22% | 32.35% | 32.46% | 32.61% | 32.11% | 30.95% | 31.19% |
| Shares in issue | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,61,98,000 | 2,62,87,794 | 2,64,37,794 | 2,64,57,111 | 2,64,84,611 | 2,65,45,962 | 6,63,98,630what Shares in issue, Mar 2025, includes. Split on 8 Jan 2025: every 2 shares became 5. Earlier filings count the shares before it. | 6,65,26,480 | 6,66,31,254 | 6,67,81,270 | 6,69,62,250 | 6,58,35,470 | 6,60,59,245 |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Jagsonpal Pharmaceuticals promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Aresko Progressive Private Limited (Trustee of Aresko Progressive Trust, in the capacity of representative) partner of J&P Investments Partnership), 20.19%. The filing names 35 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Aresko Progressive Private Limited (Trustee of Aresko Progressive Trust, in the capacity of representative) partner of J&P Investments Partnership)Indian companies, trusts and others | 20.19% | 1,33,35,635 |
| INFINITY CAPITAL (Formerly Infinity Holdings Sidecar1)Foreign companies and others | 18.00% | 1,18,88,250 |
| INFINITY HOLDINGSForeign companies and others | 16.70% | 1,10,32,550 |
| INFINITY PORTFOLIO HOLDINGSForeign portfolio investors | 8.66% | 57,17,950 |
| RAJPAL SINGH KOCHHARIndividuals and Hindu undivided families | 4.59% | 30,30,400 |
| Prithipal Singh KochharIndividuals and Hindu undivided families | 0.41% | 2,69,675 |
| Inderpal Singh KochharIndividuals and Hindu undivided families | 0.28% | 1,83,748 |
No promoter shares are reported as pledged.
Largest public holders of Jagsonpal Pharmaceuticals, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 13 Jan | Mar 2017Filed 25 Apr | Jun 2017Filed 12 Jul | Sep 2017Filed 11 Oct | Dec 2017Filed 11 Jan | Mar 2018Filed 11 May | Jun 2018Filed 12 Jul | Sep 2018Filed 16 Oct | Dec 2018Filed 23 Jan | Mar 2019Filed 20 Apr | Jun 2019Filed 18 Jul | Sep 2019Filed 19 Oct | Dec 2019Filed 17 Jan | Mar 2020Filed 13 May | Jun 2020Filed 21 Jul | Sep 2020Filed 20 Oct | Dec 2020Filed 20 Jan | Mar 2021Filed 19 Apr | Jun 2021Filed 19 Jul | Sep 2021Filed 21 Oct | Dec 2021Filed 19 Jan | Mar 2022Filed 20 Apr | Jun 2022Filed 21 Jul | Sep 2022Filed 20 Oct | Dec 2022Filed 20 Jan | Mar 2023Filed 19 Apr | Jun 2023Filed 14 Jul | Sep 2023Filed 11 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 19 Apr | Jun 2024Filed 18 Jul | Sep 2024Filed 20 Oct | Dec 2024Filed 3 Jan | Mar 2025Filed 18 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 17 Oct | Dec 2025Filed 15 Jan | Mar 2026Filed 21 Apr | Jun 2026Filed 13 Jul | Sep 2026Filed 19 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MANISH GUPTAKey managers | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.62% | 1.62% | 1.62% | 1.62% | 1.62% | 1.62% | 1.62% | – | 1.92% | 2.30% | 2.39% | 2.50% | 2.49% | 2.57% | 2.57% | 2.58% | 2.72% | 3.08% | 3.18% |
| INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRSInvestor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.56% | – | – | – | – | – | – | – | – | – | – | – | – | 1.51% | 1.50% | 1.49% | 1.49% | 1.49% |
| AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.46% | 1.46% | 1.46% | 1.46% | 1.46% | 1.46% | – | 1.45% | 1.45% | 1.47% | 1.47% |
| LINCOLN P COELHOResident individuals, over ₹2 lakh at face value | 1.15% | – | – | – | – | – | – | – | 1.15% | 1.15% | 1.15% | 1.15% | 1.15% | 1.15% | 1.15% | 1.15% | 1.15% | 1.15% | 1.16% | 1.16% | 1.16% | 1.18% | 1.18% | 1.18% | 1.18% | 1.18% | 1.18% | 1.18% | – | 1.17% | – | 1.17% | – | 1.17% | 1.17% | 1.16% | 1.16% | 1.16% | 1.18% | 1.17% |
| SANJIV KUMAR DUDEJAResident individuals, over ₹2 lakh at face value | 1.41% | 1.41% | 1.41% | 1.41% | – | – | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% | – | 1.40% | – | 1.40% | – | 1.40% | 1.39% | 1.39% | 1.39% | 1.38% | 1.41% | – |
| MUKUL MAHAVIR AGRAWALResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.77% | 1.77% | 1.77% | 1.77% | 1.77% | 1.77% | – | 1.75% | – | 1.75% | – | 1.74% | 1.74% | 1.74% | 1.73% | – | – | – |
| VANAJA SUNDAR IYERResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.78% | 2.15% | 2.15% | 2.15% | 2.15% | 2.01% | – | – | – | – | – | – | – | – | – | – | – | – |
| SI INVESTMENTS AND BROKING PRIVATE LIMITEDOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.41% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITEDOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.12% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| INVESTOR EDUCATION AND PROTECTION FUND-MCAOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.56% | 1.56% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| INVESTOR EDUCATION AND PROTECTION FUND AUTHORITYOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.56% | 1.56% | 1.56% | 1.56% | 1.56% | 1.56% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| IEPF AuthorityOther non-institutions | – | – | – | – | – | – | 1.27% | 1.27% | 1.27% | 1.45% | 1.45% | 1.45% | 1.45% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.